HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Giampiero Girolomoni Selected Research

brodalumab

1/2023Brodalumab for the treatment of plaque psoriasis in a real-life setting: a 3 years multicenter retrospective study-IL PSO (Italian landscape psoriasis).
11/2020Lichen planopilaris coexisting with plaque psoriasis effectively treated with brodalumab.
10/2020Brodalumab in the treatment of chronic plaque psoriasis.
6/2014Efficacy and safety of secukinumab in chronic plaque psoriasis and psoriatic arthritis therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Giampiero Girolomoni Research Topics

Disease

99Psoriasis (Pustulosis Palmaris et Plantaris)
05/2024 - 07/2002
35Atopic Dermatitis (Atopic Eczema)
05/2024 - 03/2002
19Inflammation (Inflammations)
03/2023 - 03/2002
17Psoriatic Arthritis
03/2024 - 06/2004
14Skin Diseases (Skin Disease)
08/2022 - 01/2002
12Allergic Contact Dermatitis
03/2010 - 01/2002
11Pruritus (Itching)
09/2022 - 03/2009
9Infections
03/2023 - 10/2005
6Eczema
09/2022 - 10/2008
6Neoplasms (Cancer)
03/2022 - 03/2010
6Dermatitis
01/2022 - 12/2003
6Virus Diseases (Viral Diseases)
12/2020 - 04/2002
6Necrosis
01/2019 - 12/2003
5Prurigo
03/2024 - 12/2013
5Pain (Aches)
03/2023 - 06/2014
4Arthritis (Polyarthritis)
03/2024 - 11/2012
4COVID-19
12/2022 - 01/2021
4Hypersensitivity (Allergy)
09/2022 - 11/2008
4Rheumatoid Arthritis
12/2020 - 01/2007
4Metabolic Syndrome (Dysmetabolic Syndrome X)
11/2020 - 10/2009
4Lichen Planus (Lichen Ruber Planus)
11/2020 - 08/2005
4Autoimmune Diseases (Autoimmune Disease)
09/2020 - 12/2014
3Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
03/2024 - 07/2014
3Obesity
06/2022 - 12/2016
3Melanoma (Melanoma, Malignant)
03/2022 - 12/2006
3Bullous Pemphigoid (Pemphigoid)
03/2022 - 01/2021
3Colorectal Neoplasms (Colorectal Cancer)
01/2011 - 01/2007
3Contact Dermatitis (Eczema, Contact)
10/2008 - 07/2003
2Basal Cell Carcinoma (Rodent Ulcer)
03/2024 - 07/2015
2Uveitis
03/2024 - 01/2018
2Hidradenitis Suppurativa
03/2024 - 01/2020
2Acne Vulgaris
01/2024 - 08/2021
2Alopecia Areata
12/2023 - 08/2021
2Pyoderma Gangrenosum
12/2022 - 11/2002
2Injection Site Reaction
12/2022 - 12/2018
2Opportunistic Infections (Opportunistic Infection)
12/2022 - 06/2004
2Blister (Bulla)
03/2022 - 12/2013
2Urticaria (Hives)
11/2021 - 03/2021
2Hypertension (High Blood Pressure)
10/2021 - 01/2019
2Dyslipidemias (Dyslipidemia)
10/2021 - 01/2019

Drug/Important Bio-Agent (IBA)

15Etanercept (Enbrel)FDA Link
12/2020 - 06/2004
13Adalimumab (Humira)FDA Link
03/2024 - 09/2007
12Biosimilar PharmaceuticalsIBA
04/2024 - 07/2014
11dupilumabIBA
03/2024 - 07/2020
11CytokinesIBA
12/2022 - 03/2002
10Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2020 - 11/2002
9Methotrexate (Mexate)FDA LinkGeneric
12/2023 - 01/2006
9Cyclosporine (Ciclosporin)FDA LinkGeneric
01/2023 - 11/2008
9secukinumabIBA
01/2023 - 06/2014
9Infliximab (Remicade)FDA Link
12/2020 - 06/2004
8Interleukin-17 (Interleukin 17)IBA
01/2023 - 06/2014
8ChemokinesIBA
07/2019 - 01/2002
7Monoclonal AntibodiesIBA
01/2024 - 08/2012
7Adrenal Cortex Hormones (Corticosteroids)IBA
03/2023 - 08/2005
6InterleukinsIBA
08/2022 - 10/2005
6AntibodiesIBA
03/2022 - 06/2004
5ixekizumabIBA
05/2024 - 06/2014
5VaccinesIBA
12/2022 - 04/2002
5HaptensIBA
11/2008 - 01/2002
4Ustekinumab (CNTO 1275)FDA Link
04/2024 - 08/2012
4Janus Kinase InhibitorsIBA
01/2024 - 01/2018
4Interleukin-12 (IL 12)IBA
01/2023 - 08/2012
4brodalumabIBA
01/2023 - 06/2014
4AllergensIBA
09/2022 - 03/2002
4ErbB Receptors (EGF Receptor)IBA
01/2021 - 07/2003
4Proteins (Proteins, Gene)FDA Link
01/2021 - 07/2002
4apremilastIBA
06/2020 - 01/2016
3upadacitinibIBA
01/2024 - 11/2023
3Interleukin-4 (Interleukin 4)IBA
12/2023 - 08/2005
3Janus KinasesIBA
11/2023 - 01/2018
3Advanced Glycation End ProductsIBA
03/2023 - 07/2017
3Interleukin-23 (Interleukin 23)IBA
01/2023 - 08/2012
3Interleukin-13IBA
12/2022 - 10/2005
3Immunoglobulin A (IgA)IBA
09/2022 - 12/2011
3Immunoglobulin G (IgG)IBA
03/2022 - 06/2014
3Imiquimod (Aldara)FDA LinkGeneric
01/2022 - 01/2017
3Antimicrobial PeptidesIBA
09/2020 - 12/2006
3EnzymesIBA
01/2019 - 04/2010
3Immunomodulating AgentsIBA
01/2018 - 07/2010
3Cetuximab (Erbitux)FDA Link
01/2016 - 01/2007
3efalizumab (Raptiva)FDA Link
01/2009 - 01/2006
3NickelIBA
11/2008 - 06/2002
2ABP 501IBA
12/2023 - 12/2022
2abrocitinibIBA
08/2023 - 09/2022
2tralokinumabIBA
07/2023 - 12/2022
2Biomarkers (Surrogate Marker)IBA
03/2023 - 01/2022
2MethylprednisoloneFDA LinkGeneric
12/2022 - 03/2022
2HLA-C Antigens (HLA-C)IBA
11/2022 - 01/2021
2NivolumabIBA
03/2022 - 10/2020
2SteroidsIBA
01/2022 - 01/2015
2Antirheumatic Agents (DMARD)IBA
01/2022 - 11/2012
2Omalizumab (Xolair)FDA Link
11/2021 - 12/2017

Therapy/Procedure

45Therapeutics
05/2024 - 11/2002
14Biological Therapy
05/2024 - 09/2007
5Transplantation
12/2020 - 05/2010
4Phototherapy (Light Therapy)
01/2022 - 12/2010
3Aftercare (After-Treatment)
09/2022 - 07/2013
3Balneology
04/2021 - 07/2008
3Drug Therapy (Chemotherapy)
01/2016 - 01/2007
3Radiotherapy
10/2015 - 12/2009